Need To Know: Analysts Are Much More Bullish On Paradeep Phosphates Limited (NSE:PARADEEP) Revenues

Paradeep Phosphates Limited (NSE:PARADEEP) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The revenue forecast for this year has experienced a facelift, with the analysts now much more optimistic on its sales pipeline.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

After this upgrade, Paradeep Phosphates' dual analysts are now forecasting revenues of ₹199b in 2026. This would be a notable 14% improvement in sales compared to the last 12 months. Statutory earnings per share are supposed to dip 4.7% to ₹10.85 in the same period. Prior to this update, the analysts had been forecasting revenues of ₹155b and earnings per share (EPS) of ₹10.45 in 2026. The most recent forecasts are noticeably more optimistic, with a very substantial lift in revenue estimates and a lift to earnings per share as well.

View our latest analysis for Paradeep Phosphates

Of course, another way to look at these forecasts is to place them into context against the industry itself. It's clear from the latest estimates that Paradeep Phosphates' rate of growth is expected to accelerate meaningfully, with the forecast 30% annualised revenue growth to the end of 2026 noticeably faster than its historical growth of 8.7% p.a. over the past three years. Compare this with other companies in the same industry, which are forecast to grow their revenue 13% annually. Factoring in the forecast acceleration in revenue, it's pretty clear that Paradeep Phosphates is expected to grow much faster than its industry.

The Bottom Line

The most important thing to take away from this upgrade is that analysts upgraded their earnings per share estimates for this year, expecting improving business conditions. They also upgraded their revenue estimates for this year, and sales are expected to grow faster than the wider market. Given that analysts appear to be expecting substantial improvement in the sales pipeline, now could be the right time to take another look at Paradeep Phosphates.

Still, the long-term prospects of the business are much more relevant than next year's earnings. We have analyst estimates for Paradeep Phosphates going out as far as 2028, and you can see them free on our platform here.

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.